Human Health | Boehringer Ingelheim MEA
Human Health
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.
Latest Articles on Human Health
Find out more about the drug discovery process at Boehringer Ingelheim
Further Topics
Heart Diseases
Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.
Metabolic Diseases
About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 2045.
Lung Diseases
Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area.
Our Responsibility
The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier, too. By delivering value through innovation, we enhance the well-being of both.
Downloads
[Read more
Opens in new tab](/content/sites/default/files/mea/2023-04/BI%20Drug%20Discovery%20Infographic_04VJ%20copy.pdf "Read more: IBI Drug Discovery Infographic_04VJ pdf"/index.html)
IBI Drug Discovery Infographic_04VJ pdf
Card Body : Description Document